Wan Du

2.8k total citations
45 papers, 2.0k citations indexed

About

Wan Du is a scholar working on Molecular Biology, Oncology and Sensory Systems. According to data from OpenAlex, Wan Du has authored 45 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 13 papers in Oncology and 9 papers in Sensory Systems. Recurrent topics in Wan Du's work include Hearing, Cochlea, Tinnitus, Genetics (9 papers), Cytokine Signaling Pathways and Interactions (9 papers) and Immune Cell Function and Interaction (5 papers). Wan Du is often cited by papers focused on Hearing, Cochlea, Tinnitus, Genetics (9 papers), Cytokine Signaling Pathways and Interactions (9 papers) and Immune Cell Function and Interaction (5 papers). Wan Du collaborates with scholars based in China, United States and United Kingdom. Wan Du's co-authors include Jing‐Yuan Fang, Hua Xiong, Jie Hong, Jilin Wang, Weiping Zou, Yingchao Wang, Wenyu Su, Yanwei Lin, Zhiping Wang and Hanzhang Wang and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Nature Immunology.

In The Last Decade

Wan Du

45 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wan Du China 25 1.0k 603 494 300 239 45 2.0k
Wojciech Jóźwicki Poland 23 525 0.5× 436 0.7× 179 0.4× 402 1.3× 136 0.6× 63 1.8k
Yanfei Jia China 24 890 0.9× 345 0.6× 385 0.8× 210 0.7× 195 0.8× 102 1.6k
Keiji Hirata Japan 28 1.2k 1.1× 1.1k 1.8× 333 0.7× 268 0.9× 402 1.7× 189 2.8k
Cong Wang China 26 1.2k 1.2× 443 0.7× 1.1k 2.1× 144 0.5× 374 1.6× 109 2.1k
Luca Beltrame Italy 22 947 0.9× 385 0.6× 548 1.1× 335 1.1× 259 1.1× 57 2.1k
Fabrice Journé Belgium 35 1.4k 1.4× 1.1k 1.9× 392 0.8× 616 2.1× 353 1.5× 113 3.3k
Xiang Huang China 24 848 0.8× 372 0.6× 517 1.0× 183 0.6× 153 0.6× 114 1.7k
Wei‐Yu Chen Taiwan 26 989 1.0× 397 0.7× 480 1.0× 206 0.7× 423 1.8× 80 2.0k
Xiaoyan Jin China 25 1.1k 1.1× 261 0.4× 599 1.2× 376 1.3× 281 1.2× 80 2.1k
Blanca Camoretti-Mercado United States 28 1.1k 1.1× 192 0.3× 324 0.7× 544 1.8× 445 1.9× 49 2.2k

Countries citing papers authored by Wan Du

Since Specialization
Citations

This map shows the geographic impact of Wan Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wan Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wan Du more than expected).

Fields of papers citing papers by Wan Du

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wan Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wan Du. The network helps show where Wan Du may publish in the future.

Co-authorship network of co-authors of Wan Du

This figure shows the co-authorship network connecting the top 25 collaborators of Wan Du. A scholar is included among the top collaborators of Wan Du based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wan Du. Wan Du is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Huang, Xiaowen, Jilin Wang, C. Zhou, et al.. (2023). Metformin Reprograms Tryptophan Metabolism to Stimulate CD8+ T-cell Function in Colorectal Cancer. Cancer Research. 83(14). 2358–2371. 58 indexed citations
2.
Tao, Yong, Verónica Lamas, Wan Du, et al.. (2023). Treatment of monogenic and digenic dominant genetic hearing loss by CRISPR-Cas9 ribonucleoprotein delivery in vivo. Nature Communications. 14(1). 4928–4928. 29 indexed citations
3.
Du, Wan, Volkan Ergin, Mingqian Huang, et al.. (2023). Rescue of auditory function by a single administration of AAV-TMPRSS3 gene therapy in aged mice of human recessive deafness DFNB8. Molecular Therapy. 31(9). 2796–2810. 19 indexed citations
4.
Yu, TaChung, Xiaowen Huang, Jilin Wang, et al.. (2022). Metformin abrogates Fusobacterium nucleatum-induced chemoresistance in colorectal cancer by inhibiting miR-361-5p/sonic hedgehog signaling-regulated stemness. British Journal of Cancer. 128(2). 363–374. 21 indexed citations
5.
Liu, Yi, et al.. (2017). GluR3B Ab’s induced oligodendrocyte precursor cells excitotoxicity via mitochondrial dysfunction. Brain Research Bulletin. 130. 60–66. 2 indexed citations
6.
Du, Wan, Dayong Wang, Bing Han, et al.. (2017). A POU3F4 Mutation Causes Nonsyndromic Hearing Loss in a Chinese X-linked Recessive Family. Chinese Medical Journal. 130(1). 88–92. 12 indexed citations
7.
Du, Wan & Jing‐Yuan Fang. (2015). Nutrients Impact the Pathogenesis and Development of Colorectal Cancer. PubMed. 2(4). 203–207. 7 indexed citations
8.
Sun, Tiantian, Wan Du, Hua Xiong, et al.. (2014). TMEFF2 Deregulation Contributes to Gastric Carcinogenesis and Indicates Poor Survival Outcome. Clinical Cancer Research. 20(17). 4689–4704. 32 indexed citations
9.
Du, Wan, Jing Cheng, Hui Ding, et al.. (2014). A rapid method for simultaneous multi-gene mutation screening in children with nonsyndromic hearing loss. Genomics. 104(4). 264–270. 45 indexed citations
10.
Wu, Shuai, Tiantian Sun, Linlin Ren, et al.. (2013). Knockdown of ZFX inhibits gastric cancer cell growth in vitro and in vivo via downregulating the ERK-MAPK pathway. Cancer Letters. 337(2). 293–300. 51 indexed citations
12.
Su, Wenyu, Jiong-Tang Li, Yun Cui, et al.. (2012). Bidirectional regulation between WDR83 and its natural antisense transcript DHPS in gastric cancer. Cell Research. 22(9). 1374–1389. 55 indexed citations
13.
Ding, Wenjuan, et al.. (2012). Auditory screening concurrent deafness predisposing genes screening in 10,043 neonates in Gansu province, China. International Journal of Pediatric Otorhinolaryngology. 76(7). 984–988. 18 indexed citations
14.
Ding, Hui, et al.. (2012). Silodosin is effective for treatment of LUTS in men with BPH: a systematic review. Asian Journal of Andrology. 15(1). 121–128. 19 indexed citations
15.
Du, Wan, Ying‐Chao Wang, Jie Hong, et al.. (2011). STAT5 isoforms regulate colorectal cancer cell apoptosis via reduction of mitochondrial membrane potential and generation of reactive oxygen species. Journal of Cellular Physiology. 227(6). 2421–2429. 29 indexed citations
16.
Du, Wan, Jie Hong, Ying‐Chao Wang, et al.. (2011). Inhibition of JAK2/STAT3 signalling induces colorectal cancer cell apoptosis via mitochondrial pathway. Journal of Cellular and Molecular Medicine. 16(8). 1878–1888. 87 indexed citations
18.
Xiong, Hua, Wan Du, Huimin Chen, et al.. (2009). Inhibition of DNA methyltransferase induces G2 cell cycle arrest and apoptosis in human colorectal cancer cells via inhibition of JAK2/STAT3/STAT5 signalling. Journal of Cellular and Molecular Medicine. 13(9b). 3668–3679. 43 indexed citations
19.
Xiong, Hua, Wenyu Su, Qinchuan Liang, et al.. (2009). Inhibition of STAT5 induces G1 cell cycle arrest and reduces tumor cell invasion in human colorectal cancer cells. Laboratory Investigation. 89(6). 717–725. 61 indexed citations
20.
Chen, Zhaofei, Qinchuan Liang, Wan Du, et al.. (2009). Inhibition of DNA methyltransferase induces G2 cell cycle arrest and apoptosis in human colorectal cancer cells via inhibition of JAK2/STAT3/STAT5 signaling. Journal of Cellular and Molecular Medicine. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026